Profit Or Loss [Abstract]

Hyloris Pharmaceuticals SA - Filing #3166256

Concept 2022-01-01 to
2022-12-31
2021-01-01 to
2021-12-31
Profit or loss [abstract]
Profit (loss) [abstract]
Revenue
2,951,000 EUR
3,096,000 EUR
Profit (loss) from operating activities
10,638,000 EUR
10,541,000 EUR
Finance income
466,000 EUR
32,000 EUR
Finance costs
594,000 EUR
773,000 EUR
Share of profit (loss) of associates and joint ventures accounted for using equity method
130,000 EUR
191,000 EUR
Profit (loss) before tax
10,766,000 EUR
11,282,000 EUR
Tax expense (income)
4,000 EUR
297,000 EUR
Profit (loss)
10,770,000 EUR
11,579,000 EUR
Profit (loss), attributable to [abstract]
Profit (loss), attributable to owners of parent
10,770,000 EUR
11,579,000 EUR
Earnings per share [text block]
Earnings per share [abstract]
Earnings per share [line items]
Basic earnings per share [abstract]
Basic earnings (loss) per share from continuing operations
0.40
0.45

Talk to a Data Expert

Have a question? We'll get back to you promptly.